Enhanced insulin response to oral glucose load in patients with angina pectoris associated with ST segment elevation in the absence of epicardial coronary arterial obstruction

Angiology

Volumn 49, Issue 10, 1998, Pages 815-826

  Nagai, Hideo ^a   Takata, Shigeo ^b   Shimakura, Atsuhiro ^a   Sakagami, Satoru ^a   Nakamura, Yukio ^a   Ohkuwa, Hitoshi ^c   Kobayashi, Ken Ichi ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Kouseiren Takaoka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; ST SEGMENT ELEVATION; SYNDROME X;

EID: 0031719510     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900905     Document Type: Article

References (49)

1. Maseri A, Crea F, Kaski JC, et al: Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 17: 499-506, 1991.
2. Cannon RO III, Camici PG, Epstein SE: Pathophysiological dilemma of syndrome X. Circulation 85:883-892, 1992.
3. Umamoto I, Matsubara K, Tsuji H, et al: A case of myocardial ischemia induced by ergonovine maleate in normal coronary arteries not accompanied with vasospasm [in Japanese]. Coronary 6:232-238, 1989.
4. Nagai H, Nakamura Y, Takata S, et al: Angina pectoris associated with ST segment elevation in the absence of epicardial coronary arterial obstruction. Angiology 45:391-397, 1994.
5. Sekiya M, Okayama H, Suzuki M, et al: Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: A possible vasospasm of small coronary arteries: A case report. Angiology 44: 811-815, 1993.
6. Yamagishi H, Itagane H, Hato K, et al: A case of rest angina due to microvascular spasm. Jpn Circ J 61: 87-89, 1997.
7. Pyorala K: Hyperinsulinemia as predictor of atherosclerotic vascular disease: Epidemiological evidence. Diabete Metab 17:87-92, 1991.
8. Despres JP, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996.
9. Shimabukuro M, Shinzato T, Higa S, et al: Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. J Am Coll Cardiol 25:356-361, 1995.
10. Shinozaki K, Suzuki M, Ikebuchi M, et al: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 92:1749-1757, 1995.
11. Suzuki M, Nishizaki M, Arita M, et al: Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. J Am Coll Cardiol 27:1458-1463, 1996.
12. Dean JD, Jones CJH, Hutchison SJ, et al: Hyperinsulinemia and microvascular angina ("syndrome X"). Lancet 337:456-457, 1991.
13. Botker HE, Moller N, Ovesen P, et al: Insulin resistance in microvascular angina (syndrome X). Lancet 342:136-140, 1993.
14. Fuh MM, Jeng CY, Young MM, et al: Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism 42: 1090-1092, 1993.
15. Chauhan A, Foote J, Petch MC, et al: Hyperinsulinemia, coronary artery disease, and syndrome X. J Am Coll Cardiol 23:364-368, 1994.
16. Ley CJ Swan J, Godsland IF, et al: Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram. J Am Coll Cardiol 23:377-383, 1994.
17. Swan JW, Walton C, Godsland IF, et al: Insulin resistance syndrome as a feature of cardiological syndrome X in nonobese men. Br Heart J 71:41-44, 1994.
18. Alexopoulos D, Olympics C, Psiroyiannis A, et al: Hyperinsulinemia in syndrome X: A marker of the syndrome? J Cardiovasc Risk 1:69-73, 1994.
19. Vestergaard H, Skott P, Steffensen R, et al: Insulin-resistant glucose metabolism in patients with microvascular angina-syndrome X. Metabolism 44: 876-882, 1995.
20. Ganz W, Tamura K, Marcus HS, et al: Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 44:181-195, 1971.
21. WHO Study Group: Definition, diagnosis, and classification: Diabetes mellitus. Technical report series 727, World Health Organization, 1985, pp 9-25.
22. Sluiter WJ, Erkelens DW, Terpstra P, et al: Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 25: 245-249, 1976.
23. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:449-502, 1972.
24. Sahn DJ, DeMaria A, Kisslo J, et al: Recommendations regarding quantitation in M-mode echocardioeraphy: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083, 1978.
25. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Circulation 55:613-618, 1977.
26. Mancini GBJ, Slutsky RA, Norris SL, et al: Radionuclide analysis of peak filling rate, filling fraction, and time to peak filling rate. Am J Cardiol 51:43-51, 1983.
27. Wilson RF, Laxson DD, Lesser JR, et al: Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1:807-811, 1989.
28. Tomoike H, Egashira K, Yamada A, et al: Leukotriene C4- and D4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram: Angiographic analysis. Circulation 76:480-487, 1987.
29. Clarke JG, Davies GJ, Kerwin R, et al: Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1:1057-1059, 1987.
30. Larkin SW, Clarke JG, Keogh BE, et al: Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 64:956-958, 1989.
31. McFadden EP, Clarke JG, Davies GJ, et al: Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 324:648-654, 1991.
32. Newman CM, Maseri A, Hackett DR, et al: Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 66:1070-1076, 1990.
33. Horio Y, Yasue H, Okumura K, et al: Effects of intracoronary injection of acetylcholine on coronary arterial hemodynamics and diameter. Am J Cardiol 62:887-891, 1988.
34. Flack JM, Sowers JR: Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 91 (Suppl 1A):11S-21S, 1991.
35. Cannon RO III, Watson RM, Rosing DR, et al: Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1:1359-1373, 1983.
36. Bugiardini R, Borghi A, Biagetti L, et al: Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol 63:286-290, 1989.
37. Bortone AS, Hess OM, Eberli FR, et al: Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve. Circulation 79:516-527, 1989.
38. Montorsi P, Manfredi M, Loaldi A, et al: Comparison of coronary vasomotor responses to nifedipine in syndrome X and in Prinzmetal's angina pectoris. Am J Cardiol 63:1198-1202, 1989.
39. Galassi AR, Kaski JC, Pupita G, et al: Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol 64:264-269, 1989.
40. Werns SW, Walton JA, Hsia HH, et al: Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 79:287-291, 1989.
41. Motz W, Vogt M, Rabenau O, et al: Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 68:996-1003, 1991.
42. Vrints CJM, Bult H, Hitter E, et al: Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol 19:21-31, 1992.
43. Quyyumi AA, Cannon RO III, Panze JA, et al: Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 86:1864-1871, 1992.
44. Egashira K, Inou T, Hirooka Y, et al: Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 328:1659-1664, 1993.
45. Saenz de Tejada I, Goldstein I, Azadzoi K, et al: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025-1030, 1989.
46. Panze JA, Quyyumi AA, Brush JE, et al: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-27, 1990.
47. Pfeifle B, Ditschuneit H: Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 20:155-158, 1981.
48. Julius S, Gudbrandsson T, Jamerson K, et al: The hemodynamic link between insulin resistance and hypertension. J Hypertens 9:983-986, 1991.
49. Sax FL, Cannon RO III, Hanson C, et al: Impaired forearm vasodilator reserve in patients with microvascular angina. N Engl J Med 317:1366-1370, 1987.